Carsten F.J Bakhuis, UMC Utrecht, Utrecht, Netherlands, tells us more about the potential implications of intra-tumoral hypoxia in Pregnancy-Associated Breast Cancer (PABC). Patients with tumors overexpressing hypoxia-markers have a significantly worse survival, which may be an important underlying carcinogenic mechanism in PABC, thereby holding the potential as a promising novel therapeutic target in this patient group. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.